Sign in
Taking people in United StatesNo phase

Implanted electrical stimulator to steady the trunk in people with spinal cord injury

Tests an implanted stimulator for sitting stability in people with spinal cord injury.

Key facts

Who runs it
VA Office of Research and Development
Where
Cleveland, United StatesSee the site
Trial code
Registry title
A Neuroprosthesis for Seated Posture and Balance
Status
Recruiting
People taking part
10 people, planned
Started
30 Nov 2011
Expected to end
31 Jan 2028
Type of study
Interventional
Treatments tested
  • IRS-8 (8-Channel implanted stimulator-telemeter)
Record updated
26 October 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with a spinal cord injury who will get an implanted device. The device uses small electric currents to steady the trunk and hips.

Age
21 years and older
Sex
All sexes
Disease stage
Spinal cord injury at level C4 to T12, ASIA Scale A through C, more than 6 months after the injury. Trunk and pelvis muscles must still have working nerves and respond to stimulation.

Main reasons for not taking part

  • Pregnancy
  • Cannot speak and read English
  • Acute or chronic psychological problems or chemical dependency
  • History of balance problems, spontaneous falls, spontaneous fractures or low bone density
  • Uncontrolled spasticity, hip flexion or adduction spasms, or acute orthopaedic or medical problems

The registry criteria, word for word

Show all 16 criteriaShow less

Who can take part

  • C4-T12
  • ASIA Scale A through C
  • Time post injury greater than 6 months
  • Innervated and excitable trunk and pelvis musculature
  • Absence of acute or chronic psychological problems or chemical dependency
  • Range of motion within normal limits
  • Controlled spasticity and absence of hip flexion and adduction spasm
  • Height and weight within normal limits
  • No history of balance problems or spontaneous falls
  • No history of spontaneous fracture or evidence low bone density
  • No acute orthopaedic problems
  • No acute medical complications
  • Adequate social support and stability
  • Able to speak and read English

Who cannot take part

  • Pregnancy
  • Non-English speaking

Where in United States

  • Louis Stokes VA Medical Center, Cleveland, OHCleveland, United StatesContact: Lisa M Lombardo, MPTTaking people

About the trial

What the trial wants to find out

The purpose of this study is to evaluate a surgically implanted functional electrical stimulation (FES) system to facilitate stability of the trunk and hips. FES involves applying small electric currents to the nerves, which cause the muscles to contract. This study evaluates how stabilizing and stiffening the trunk with FES can change the way spinal cord injured volunteers sit, breathe, reach, push a wheelchair, or roll in bed.

The group in the trial

  • NeuroprosthesisTreatment being tested

    Volunteers are evaluated for appropriateness for inclusion in the study on an intent-to-treat basis. Qualifying candidates all receive the implanted neuroprosthesis and participate in post-operative training and follow-up procedures.

    Treatment: IRS-8 (8-Channel implanted stimulator-telemeter)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
A Neuroprosthesis for Seated Posture and Balance
Plain-language title
Implanted electrical stimulator to steady the trunk in people with spinal cord injuryGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
26 October 2026